Advances in Hematological Malignancies
Recent centuries have witnessed remarkable progress in the domain of hematological malignancies. Novel approaches such as targeted drugs, immunotherapies, and gene editing are transforming the survival rates for patients with blood cancers. Research studies continue to explore these innovative strategies, offering potential for more curative treatm